Cassava Sciences | PTIE - Liquidités





Liquidités Changement Date
Abbott USD 6.8B 1.72B 2026-03
Amgen USD 12.04B 2.91B 2026-03
Biogen USD 3.38B 374.2M 2026-03
Cara Therapeutics USD 21.42M 770K 2025-09
Cassava Sciences USD 106.08M 6.3M 2025-09
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 5.28B 1.99B 2026-03
Geron USD 79.44M 553K 2025-12
J&J USD 21.69B 1.98B 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 240.63M 27.39M 2025-12
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06